Advances in the management of acute nonlymphocytic leukemia.
D000208:Acute Disease; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001803:Blood Transfusion; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use; D003630:Daunorubicin / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006098:Granulocytes / Q000637:transplantation; D006470:Hemorrhage / Q000209:etiology / Q000628:therapy; D006801:Humans; D007167:Immunotherapy; D017053:Infection Control; D007239:Infections / Q000209:etiology / Q000628:therapy; D007674:Kidney Diseases / Q000517:prevention & control; D007938:Leukemia / Q000150:complications / Q000628:therapy*; D017713:Platelet Transfusion; D014184:Transplantation, Homologous
D000900:Anti-Bacterial Agents; D003561:Cytarabine; D003630:Daunorubicin